Drug Shortage Report for JAMP-CHOLESTYRAMINE

Last updated on 2024-08-22 History
Report ID 211780
Drug Identification Number 02478595
Brand name JAMP-CHOLESTYRAMINE
Common or Proper name Cholestyramine for Oral Suspension
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) CHOLESTYRAMINE RESIN
Strength(s) 4G
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 30
ATC code C10AC
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-11-27
Estimated end date 2024-09-30
Actual end date 2024-08-21
Shortage status Resolved
Updated date 2024-08-22
Company comments Under allocation
Health Canada comments
Tier 3 Status Yes
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2024-08-22 English Compare
v13 2024-08-21 French Compare
v12 2024-08-21 English Compare
v11 2024-08-14 French Compare
v10 2024-08-14 English Compare
v9 2024-07-05 French Compare
v8 2024-07-05 English Compare
v7 2024-06-11 French Compare
v6 2024-06-11 English Compare
v5 2024-02-06 French Compare
v4 2024-02-06 English Compare
v3 2024-01-30 English Compare
v2 2023-11-28 French Compare
v1 2023-11-28 English Compare

Showing 1 to 14 of 14